Acute arterial occlusion as the presenting feature in acute promyelocytic leukaemia.
Kalk
E
E
Department of Haematology, Pathology Laboratory, Warwick Hospital, Warwickshire, UK.
Basu
S
S
Rose
P
P
Chachlani
N
N
D000671:Amputation, Surgical; D000925:Anticoagulants / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000209:etiology* / Q000601:surgery; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005260:Female; D005534:Foot Diseases / Q000209:etiology* / Q000601:surgery; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications* / Q000601:surgery; D008875:Middle Aged; D009336:Necrosis; D011150:Popliteal Artery; D013866:Thioguanine / Q000008:administration & dosage; D014212:Tretinoin / Q000627:therapeutic use
D000925:Anticoagulants; D003561:Cytarabine; D014212:Tretinoin; D006493:Heparin; D013866:Thioguanine; D003630:Daunorubicin